
|Articles|August 14, 2018
CEO of Aerie Pharmaceuticals provides a brief company overview at OIS meeting
Advertisement
Vince Anido, Chairman & Chief Executive Officer of Aerie Pharmaceuticals, Inc., provides an update on the company's glaucoma drugs at the Ophthalmology Innovation Summit (OIS) meeting during the annual American Society of Retina Specialists (ASRS) conference in Vancouver, British Columbia, on July 20th, 2018.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Modern Retina
1
Altered ipRGC circuits and function may translate to disrupted sleep and circadian rhythms in Alzheimer’s disease
2
StemSight gains patent for off-the-shelf limbal stem cell platform patent milestone for STE-101
3
CTS 2026: OTX-TKI demonstrates superiority over aflibercept in wet AMD—what the SOL-1 data mean for retina practice
4
Ranluspec FDA approval: Cyrus Karkaria, PhD, on biosimilar access, prefilled syringes, and long-term switching confidence
5




















